No-ATG | ATG | p value | |
---|---|---|---|
Total number of patients | 421 | 145 | |
Engraftment, n (%) | 411 (98.6%) | 145 (100%) | 0.15 |
No engraftment, n (%) | 6 (1.4%) | 0 (0%) | |
Missing, n | 5 | 0 | |
Median time ANC > 0.5 G/L (days, range) | 15 (5–45) | 14 (5–28) | 0.001 |
Acute GVHD, | |||
Grade 0–I, n (%) | 315 (78.2%) | 116 (84.7%) | 0.10 |
Grade II–IV, n (%) | 88 (21.8%) | 21 (15.3%) | |
Grade III–IV, n (%) | 31 (7.7%) | 6 (4.4%) | 0.19 |
Missing, n | 5 | 3 | |
Chronic GVHDa | |||
All grades | 52% (46–57.7) | 30.8% (22.3–39.8) | 0.00026 |
Extensive | 26.3% (21.2–31.6) | 7.6% (3.5–13.7) | 4.7 × 10−5 |
Limited, n | 71 | 26 | |
Extensive; n | 77 | 8 | |
Missing, n | 117 | 28 |